Unknown PHASE1 INTERVENTIONAL NCT00205595

Normal Binding of R-[11C]PK11195 in Human Subjects

The Distribution and Quantification of Specific Binding of the Positron Emission Tomography Tracer R)-[11C]PK11195 in Normal Human Subjects

Sponsor: Amsterdam UMC, location VUmc

Conditions Normal Aging

Interventions Positron Emission Tomography

Updated 6 times since 2017 Last updated: Jul 3, 2008 Started: Feb 28, 2001 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00205595, this PHASE1 trial focuses on Normal Aging and remains ongoing. Sponsored by Amsterdam UMC, location VUmc, it has been updated 6 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
May 2022 — Jul 2024 [monthly]

Unknown Status PHASE1
Jan 2021 — May 2022 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Feb 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amsterdam UMC, location VUmc

Data source: Amsterdam UMC, location VUmc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amsterdam, Netherlands